Product Description: TC-S 7005 is a Polo-like kinases (Plks) inhibitor with IC50s of 4 nM, 24 nM and 214 nM for Plk2, Plk3, and Plk1, respectively[1].
Applications: COVID-19-anti-virus
Formula: C21H17N3O3
References: [1]Hanan EJ, et al. Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitors. Bioorg Med Chem Lett. 2008 Oct 1;18(19):5186-9./[2]Stephan Reinhard Künzel, et al. Hypoxia-induced epigenetic silencing of polo-like kinase 2 promotes fibrosis in atrial fibrillation. bioRxiv 445098
CAS Number: 1082739-92-1
Molecular Weight: 359.38
Compound Purity: 99.68
Research Area: Inflammation/Immunology; Cardiovascular Disease
Solubility: DMSO : 125 mg/mL (ultrasonic)
Target: Polo-like Kinase (PLK)